Association between potassium concentrations, variability and supplementation, and in-hospital mortality in ICU patients: a retrospective analysis.

Lilian Jo EngelhardtFelix BalzerMichael C MüllerJulius J GrunowClaudia D SpiesKenneth B ChristopherSteffen Weber-CarstensTobias Wollersheim

Published in: Annals of intensive care (2019)

ICU patients may benefit from a target range between 3.5 and 4.0 mmol/l and a minimal potassium variability. Clear potassium target ranges have to be determined. Criteria for widely applied potassium supplementation should be critically discussed. Trial registration German Clinical Trials Register, DRKS00016411. Retrospectively registered 11 January 2019, http://www.drks.de/DRKS00016411.

Keyphrases

clinical trial
end stage renal disease
ejection fraction
newly diagnosed
intensive care unit
peritoneal dialysis
prognostic factors
randomized controlled trial
mechanical ventilation
phase ii